| Primary |
| Hypertension |
36.8% |
| Product Used For Unknown Indication |
14.5% |
| Dyslipidaemia |
6.1% |
| Constipation |
4.8% |
| Diabetes Mellitus |
4.8% |
| Atrial Fibrillation |
4.4% |
| Essential Hypertension |
3.9% |
| Insomnia |
3.5% |
| Type 2 Diabetes Mellitus |
3.5% |
| Hyperuricaemia |
2.6% |
| Cerebral Infarction |
2.2% |
| Angina Pectoris |
1.8% |
| Depression |
1.8% |
| Gastric Ulcer |
1.8% |
| Myocardial Infarction |
1.8% |
| Osteoporosis |
1.8% |
| Thrombosis Prophylaxis |
1.3% |
| Bronchitis |
0.9% |
| Hyperlipidaemia |
0.9% |
| Infection |
0.9% |
|
| Hyponatraemia |
14.6% |
| Renal Failure Acute |
14.6% |
| Hypotension |
7.3% |
| Death |
4.9% |
| Headache |
4.9% |
| Hyperkalaemia |
4.9% |
| Hyperuricaemia |
4.9% |
| Hypoglycaemia |
4.9% |
| Loss Of Consciousness |
4.9% |
| Orthostatic Hypotension |
4.9% |
| Pneumonia |
4.9% |
| Retinal Artery Occlusion |
4.9% |
| Angina Unstable |
2.4% |
| Asthenia |
2.4% |
| Blood Potassium Increased |
2.4% |
| Cardiac Arrest |
2.4% |
| Cerebral Haematoma |
2.4% |
| Cerebral Infarction |
2.4% |
| Convulsion |
2.4% |
| Cough |
2.4% |
|
| Secondary |
| Product Used For Unknown Indication |
31.1% |
| Hypertension |
28.2% |
| Pneumonia |
8.6% |
| Type 2 Diabetes Mellitus |
4.8% |
| Cardiac Failure |
3.8% |
| Cardiac Failure Chronic |
3.8% |
| Atrial Fibrillation |
3.3% |
| Depression |
2.9% |
| Dyslipidaemia |
2.9% |
| Cancer Pain |
1.9% |
| Prostate Cancer |
1.9% |
| Bronchitis |
1.0% |
| Insomnia |
1.0% |
| Metastases To Bone |
1.0% |
| Pancreatitis Acute |
1.0% |
| Von Willebrand's Disease |
1.0% |
| Angina Pectoris |
0.5% |
| Anxiety |
0.5% |
| Asthma |
0.5% |
| Bowel Preparation |
0.5% |
|
| Hyponatraemia |
19.3% |
| Renal Failure Acute |
17.5% |
| Circulatory Collapse |
8.8% |
| Hypotension |
8.8% |
| Interstitial Lung Disease |
7.0% |
| Urinary Tract Infection |
5.3% |
| Blindness Unilateral |
3.5% |
| Disorientation |
3.5% |
| Dyspnoea |
3.5% |
| Fall |
3.5% |
| Muscle Spasms |
3.5% |
| Abdominal Pain |
1.8% |
| Blood Creatinine Increased |
1.8% |
| Blood Potassium Increased |
1.8% |
| Blood Urea Increased |
1.8% |
| Blood Urine Present |
1.8% |
| Cardiac Arrest |
1.8% |
| Cholestasis |
1.8% |
| Confusional State |
1.8% |
| Drug Abuse |
1.8% |
|
| Concomitant |
| Hypertension |
32.2% |
| Product Used For Unknown Indication |
12.9% |
| Type 2 Diabetes Mellitus |
6.6% |
| Rheumatoid Arthritis |
6.1% |
| Hepatitis C |
5.7% |
| Diabetes Mellitus |
4.8% |
| Hypercholesterolaemia |
4.2% |
| Atrial Fibrillation |
3.3% |
| Multiple Myeloma |
3.3% |
| Insomnia |
2.9% |
| Pain |
2.4% |
| Prophylaxis |
2.0% |
| Asthma |
1.8% |
| Autonomic Nervous System Imbalance |
1.8% |
| Breast Cancer |
1.8% |
| Ill-defined Disorder |
1.8% |
| Dyslipidaemia |
1.7% |
| Osteoporosis |
1.7% |
| Diabetic Foot Infection |
1.5% |
| Gastritis Prophylaxis |
1.5% |
|
| Syncope Vasovagal |
9.0% |
| Alveolitis Allergic |
6.0% |
| Anaemia |
6.0% |
| Haematochezia |
6.0% |
| Myocardial Infarction |
6.0% |
| Oedema Peripheral |
6.0% |
| Platelet Count Decreased |
6.0% |
| Acute Myeloid Leukaemia |
4.5% |
| Asthenia |
4.5% |
| Cerebral Infarction |
4.5% |
| Decreased Appetite |
4.5% |
| Delirium |
4.5% |
| Gastritis Atrophic |
4.5% |
| Nephrogenic Anaemia |
4.5% |
| Osteoporosis |
4.5% |
| Palpitations |
4.5% |
| Somnolence |
4.5% |
| Wrong Technique In Drug Usage Process |
4.5% |
| Acute Leukaemia |
3.0% |
| Blood Bilirubin Increased |
3.0% |
|
| Interacting |
| Product Used For Unknown Indication |
45.8% |
| Insomnia |
33.3% |
| Anxiety |
16.7% |
| Ascites |
4.2% |
|
| Drug Interaction |
33.3% |
| Rhabdomyolysis |
33.3% |
| Disorientation |
16.7% |
| Hyperkalaemia |
16.7% |
|
